NICKLAUS CHILDRENS HOSPITAL
1. Target Overview & Investment Thesis
NICKLAUS CHILDRENS HOSPITAL is a 259-bed suburban community hospital in MIAMI-DADE, FL with $769.3M in net patient revenue and a 5.5% operating margin. The hospital serves a payer mix of 0.1% Medicare, 10.2% Medicaid, and 89.7% commercial.
Thesis: Platform Growth. Our ML models identify $56.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.5% to 12.9% (+736bps).
| Net Revenue HCRIS | $769.3M |
| Current EBITDA COMPUTED | $42.4M |
| Operating Margin COMPUTED | 5.5% |
| Occupancy HCRIS | 64.4% |
| Revenue / Bed COMPUTED | $3.0M |
| Net-to-Gross HCRIS | 32.2% |
| Distress Probability ML | 43.3% |
2. Market Context & Competitive Position
FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 5.5% places it above the state median. Among 109 size-comparable peers (130-518 beds), the median margin is 2.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (130-518), prioritizing same-state peers. 109 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| NICKLAUS CHILDRENS HOSPITAL (Target) | FL | 259 | $769.3M | 5.5% |
| MOFFITT CANCER CENTER | FL | 218 | $1.91B | 16.0% |
| MAYO CLINIC FLORIDA | FL | 304 | $1.09B | 21.6% |
| MOUNT SINAI MEDICAL CENTER OF | FL | 481 | $904.2M | 12.2% |
| TALLAHASSEE MEMORIAL HOSPITAL | FL | 483 | $871.6M | -4.8% |
| SHANDS JACKSONVILLE MEDICAL CE | FL | 481 | $861.4M | -7.1% |
| HCA FLORIDA OCALA HOSPITAL | FL | 509 | $761.7M | 27.6% |
| MEMORIAL HOSPITAL WEST | FL | 486 | $741.4M | 5.2% |
| SOUTH MIAMI HOSPITAL | FL | 375 | $688.4M | 11.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $56.6M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $16.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $15.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $15.2M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $9.4M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $492K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $42.4M |
| + RCM Uplift | +$56.6M |
| Pro Forma EBITDA | $99.0M |
| Current Margin | 5.5% |
| Pro Forma Margin | 12.9% |
| WC Released (1x) | $29.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $65.2M | $845.8M | 12.97x | 67.0% |
| Base (11x exit) | 10.0x | 11.0x | $65.2M | $951.5M | 14.60x | 70.9% |
| Bull Case | 9.0x | 11.0x | $58.7M | $1.16B | 19.76x | 81.6% |
| Bull (12x exit) | 9.0x | 12.0x | $58.7M | $1.28B | 21.86x | 85.3% |
| Bear Case | 11.0x | 10.0x | $71.7M | $541.5M | 7.55x | 49.8% |
| Bear (11x exit) | 11.0x | 11.0x | $71.7M | $618.9M | 8.63x | 53.9% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 109 hospitals with 130-518 beds
- Same-state prioritization (n=110)
- Comp margins: P25=-5.2% / P50=2.8% / P75=17.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.